首页 社会内容详情
皇冠网址app(www.hg108.vip):Jump in net profit, revenue for Supercomnet

皇冠网址app(www.hg108.vip):Jump in net profit, revenue for Supercomnet

分类:社会

网址:

SEO查询: 爱站网 站长工具

点击直达

皇冠管理端登3网站皇冠管理端登3网站(www.99cx.vip)实时更新发布最新最快最有效的皇冠管理端登3网站手机网址,包括新2登3手机网址,新2登3备用网址,皇冠登3最新网址,新2足球登3网址,新2网址大全。

KUALA LUMPUR: Supercomnet Technologies Bhd’s (Scomnet) net profit surged 73.8% to RM9.4mil, or 1.23 sen earnings per share in the second quarter ended June 30 (2Q), compared with RM5.4mil, or 0.75 sen a year ago.

The medical devices manufacturer attributed the higher earnings to improved efficiencies, which resulted in better sales of higher margin products, namely in its medical segment. It was further helped by a favourable foreign exchange rate.

Its revenue for the quarter rose 21.71% to RM39.86mil against RM32.75mil posted in the previous corresponding period, driven by higher demand from the automotive, medical and industrial segments.

The group also saw its net profit margin grow from 16.51% in the last corresponding period to 23.59% in 2Q.

“We are in a situation now where we are working hard to meet the demand of our clients, both for the medical and automotive segment.

,

皇冠网址appwww.hg108.vip)是一个开放皇冠官方网址代理APP下载、皇冠官方网址会员APP下载、皇冠官方网址线路APP下载、皇冠官方网址登录APP下载的官方平台。皇冠体育官方网址APP上最新登录线路、新2皇冠官方网址更新最快。皇冠体育网址APP开放皇冠官方会员注册、皇冠官方代理开户等业务。

,

“While the medical segment is our key contributor profit-wise, we are also seeing a lot of demand and orders from the automotive segment. In the coming quarters, we expect revenue from the automotive segment to catch up to the medical segment level gradually.

“Profit will still largely continue to come from the medical segment,” managing director James Shiue said in a statement.

For the first six months, Scoment's net profit surged 62.3% to RM16.8mil from RM10.3mil previously while revenue expanded 7.84% from RM70.32mil to RM75.83mil.

“We remain optimistic about the group's mid-to long-term prospects underpinned by continuous growing customer demand, very visible orders at hand and several new products in the pipeline.

“In the remaining quarters of FY22, we expect one of our new medical products to start contributing to our revenue, after a very long wait,” Shiue said.


转载说明:本文转载自Sunbet。
 当前暂无评论,快来抢沙发吧~

发布评论